pyridoxine has been researched along with Nervous System Diseases in 66 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The only well-established human vitamin neurotoxic effects are those due to hypervitaminosis A (pseudotumor cerebri) and pyridoxine (sensory neuropathy)." | 4.78 | Vitamin neurotoxicity. ( Snodgrass, SR, 1992) |
| "Over the past 10 years the reported incidence of acute isoniazid (INH)-related poisonings has increased, with 507 cases reported in 1996." | 3.70 | Acute isoniazid exposures and antidote availability. ( Linakis, JG; Santucci, KA; Shah, BR, 1999) |
| "Ninety-eight patients with metastatic breast cancer, heavily pretreated with other agents, were entered in a phase II trial of hexamethylmelamine (HEX)." | 2.65 | Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study. ( Balcerzak, S; Fabian, CJ; Haut, A; Rasmussen, S; Smith, F; Stephens, R; Tranum, B, 1979) |
| " Is pyridoxine safe for long-term use in large segments of the population, including children? The studies on children with Down's syndrome and autism, utilizing much higher doses than are used for other therapeutic purposes, seem to indicate relative safety if carefully monitored." | 2.38 | Vitamin B6 in clinical neurology. ( Bernstein, AL, 1990) |
| "Pyridoxine toxicity was manifest as deficits in simple and precise locomotion and sensory nerve function and as degeneration of large-diameter/large-fiber spinal sensory neurons." | 1.30 | Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy. ( Cavnor, C; Cliffer, KD; Curtis, R; DiStefano, PS; Helgren, ME; Lindsay, RM; Torrento, K; Wiegand, SJ, 1997) |
| "Pyridoxine was discontinued at the first sign of either clinical or laboratory abnormality." | 1.28 | Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. ( Apfel, S; Berger, AR; Reynolds, R; Schaumburg, HH; Schroeder, C, 1992) |
| "A metallothionein-like protein has been identified recently in the rat brain which resembles in some but not all aspects a hepatic metallothionein." | 1.27 | Zinc-binding proteins in the brain. ( Ebadi, M; Hama, Y, 1986) |
| "Pyridoxine-treated dogs had proprioceptive loss involving both fore- and hindquarters, characterized by stiff, spastic, dysmetric leg movements." | 1.26 | The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. I. Clinical disease. ( Carlton, WW; Hoover, DM, 1981) |
| "Pyridoxine-treated dogs had lesions limited to tracts and nerves with neuronal bodies of their nerve fibers in the spinal and trigeminal ganglia." | 1.26 | The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. II. Pathology. ( Carlton, WW; Hoover, DM, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 51 (77.27) | 18.7374 |
| 1990's | 8 (12.12) | 18.2507 |
| 2000's | 5 (7.58) | 29.6817 |
| 2010's | 1 (1.52) | 24.3611 |
| 2020's | 1 (1.52) | 2.80 |
| Authors | Studies |
|---|---|
| Calderón-Ospina, CA | 1 |
| Nava-Mesa, MO | 1 |
| Kittisupamongkol, W | 1 |
| Noureen, N | 1 |
| Rana, MT | 1 |
| Levine, S | 1 |
| Saltzman, A | 1 |
| Arkaravichien, T | 1 |
| Sattayasai, N | 1 |
| Daduang, S | 1 |
| Sattayasai, J | 1 |
| Carlson, HB | 1 |
| Anthony, EM | 1 |
| Russell, WF | 1 |
| Middlebrook, G | 1 |
| CELICE, J | 1 |
| DUCHESNAY, G | 1 |
| FEITELEVICH, J | 1 |
| SEBASTIAN HERRADOR, M | 1 |
| ORTIZ MANCHADO, O | 1 |
| DE CASTRO DEL POZO, S | 1 |
| FERNANDEZ MARCOS, E | 1 |
| DE LA FUENTE GOMEZ, L | 1 |
| PRITZSCHE, G | 1 |
| STOERGER, R | 1 |
| MENGI, E | 1 |
| REINHARDT, G | 1 |
| BLEI, M | 1 |
| LEVIN, E | 1 |
| ARNOULD, G | 1 |
| LAXENAIRE, M | 1 |
| THIRIET, M | 1 |
| WEBER, M | 1 |
| REGNIER, F | 1 |
| KRIUKOVA, NA | 1 |
| MIZUTAME, A | 1 |
| DEGUCHI, T | 1 |
| Leonard, JV | 1 |
| TELLO MARGELI, F | 1 |
| Carlton, WW | 3 |
| Langohr, HD | 1 |
| Petruch, F | 1 |
| Schroth, G | 1 |
| Hoover, DM | 2 |
| Coleman, CN | 1 |
| Hirst, VK | 1 |
| Brown, DM | 1 |
| Halsey, J | 1 |
| Mitwalli, A | 1 |
| Blair, G | 1 |
| Oreopoulos, DG | 1 |
| Schaeppi, U | 2 |
| Krinke, G | 2 |
| Pool, KD | 1 |
| Feit, H | 1 |
| Kirkpatrick, J | 1 |
| Siskind, MS | 1 |
| Thienemann, D | 1 |
| Kirlin, L | 1 |
| Helgren, ME | 1 |
| Cliffer, KD | 1 |
| Torrento, K | 1 |
| Cavnor, C | 1 |
| Curtis, R | 1 |
| DiStefano, PS | 1 |
| Wiegand, SJ | 1 |
| Lindsay, RM | 1 |
| Santucci, KA | 1 |
| Shah, BR | 1 |
| Linakis, JG | 1 |
| Kuroda, Y | 1 |
| Naito, E | 1 |
| Ito, M | 1 |
| Saurugg, D | 1 |
| Hodkewitsch, E | 1 |
| Fabian, CJ | 1 |
| Rasmussen, S | 1 |
| Stephens, R | 1 |
| Haut, A | 1 |
| Smith, F | 1 |
| Balcerzak, S | 1 |
| Tranum, B | 1 |
| Naess, K | 1 |
| Snodgrass, SR | 1 |
| Berger, AR | 1 |
| Schaumburg, HH | 1 |
| Schroeder, C | 1 |
| Apfel, S | 1 |
| Reynolds, R | 1 |
| Santoro, L | 1 |
| Ragno, M | 1 |
| Nucciotti, R | 1 |
| Barbieri, F | 1 |
| Caruso, G | 1 |
| Bernstein, AL | 1 |
| Bendich, A | 1 |
| Cohen, M | 1 |
| Vukelja, SJ | 1 |
| Lombardo, FA | 1 |
| James, WD | 1 |
| Weiss, RB | 1 |
| Ikeda, A | 1 |
| Shimamoto, Y | 1 |
| Oda, K | 1 |
| Sano, M | 1 |
| Aoki, Y | 1 |
| Matsuzaki, M | 1 |
| Sueoka, E | 1 |
| Yamaguchi, M | 1 |
| Suzuki, H | 1 |
| Xu, Y | 1 |
| Sladky, JT | 1 |
| Brown, MJ | 1 |
| Bowe, CM | 1 |
| Veale, K | 1 |
| Brush, MG | 1 |
| Perry, M | 1 |
| de Zegher, F | 1 |
| Przyrembel, H | 1 |
| Chalmers, RA | 1 |
| Wolff, ED | 1 |
| Huijmans, JG | 1 |
| Merrill, AH | 1 |
| Henderson, JM | 1 |
| Bethwaite, P | 1 |
| Dalton, K | 1 |
| Dalton, MJ | 1 |
| Goldblatt, D | 1 |
| Ebadi, M | 1 |
| Hama, Y | 1 |
| Hamfelt, A | 1 |
| Wetterberg, L | 1 |
| Husemann, F | 1 |
| Kugler, J | 1 |
| Frank, I | 1 |
| Kanig, K | 1 |
| McVicar, M | 1 |
| Gauthier, B | 1 |
| Goodman, CT | 1 |
| Pluvinage, R | 1 |
| Vannotti, A | 1 |
| Brogi, L | 1 |
| Avesani, A | 1 |
| Gries, CL | 1 |
| Scott, ML | 1 |
| Agostini, L | 1 |
| Yonezawa, T | 1 |
| Mori, T | 1 |
| Nakatani, Y | 1 |
| Bergamini, L | 1 |
| Morris, JS | 1 |
| Ajdukiewicz, AB | 1 |
| Read, AE | 1 |
| An, AS | 1 |
| D'iachenko, VA | 1 |
| Ivanov, VI | 1 |
| Talin, AP | 1 |
| Schneider, H | 1 |
| Meeuwisse, G | 1 |
| Gamstorp, I | 1 |
| Tryding, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of the Nutritional Support System (NSS) on Neuromotor Alterations in Patients With Cerebral Palsy[NCT05648422] | 144 participants (Anticipated) | Interventional | 2023-01-16 | Recruiting | |||
| Double Blind Evaluation of Gamma-aminobutyric Acid Tartarate 100 mg, Glutamic Acid 100 mg, Dibasic Calcium Phosphate 50 mg, Thiamine Nitrate 25 mg, Pyridoxine Chloride 10 mg and Cyanocobalamin 5 mcg Versus Ginger for Vertigo-kinetosis[NCT05221892] | Phase 4 | 334 participants (Actual) | Interventional | 2021-11-22 | Completed | ||
| Multicentre Randomized Phase II Study of Neoadjuvant Trastuzumab Plus Docetaxel With and Without Bevacizumab and Trastuzumab Plus Docetaxel Plus Non-pegylated Liposome-encapsulated Doxorubicin (NPLD) With and Without Bevacizumab in HER2-positive Early Bre[NCT01367028] | Phase 2 | 100 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for pyridoxine and Nervous System Diseases
| Article | Year |
|---|---|
B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin.
Topics: Animals; Central Nervous System; Humans; Nervous System Diseases; Nervous System Physiological Pheno | 2020 |
B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin.
Topics: Animals; Central Nervous System; Humans; Nervous System Diseases; Nervous System Physiological Pheno | 2020 |
B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin.
Topics: Animals; Central Nervous System; Humans; Nervous System Diseases; Nervous System Physiological Pheno | 2020 |
B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin.
Topics: Animals; Central Nervous System; Humans; Nervous System Diseases; Nervous System Physiological Pheno | 2020 |
Recent advances in amino acid and organic acid metabolism.
Topics: Acids; Amino Acids; Animals; Biochemistry; Glutamate-Ammonia Ligase; Humans; Nervous System Diseases | 2007 |
Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature.
Topics: Aged; Aged, 80 and over; Female; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Nerv | 1993 |
[Vitamin dependency syndrome].
Topics: Biotin; Diagnosis, Differential; Folic Acid; Humans; Metabolism, Inborn Errors; Nervous System Disea | 2000 |
Vitamin neurotoxicity.
Topics: Abnormalities, Drug-Induced; Animals; Ascorbic Acid; Avitaminosis; Blood-Brain Barrier; Carrier Prot | 1992 |
Vitamin B6 in clinical neurology.
Topics: Animals; Carpal Tunnel Syndrome; Chronic Disease; Depression; Headache; Humans; Movement Disorders; | 1990 |
Vitamin B6 safety issues.
Topics: Abnormalities, Drug-Induced; Animals; Humans; Nervous System Diseases; Pyridoxine | 1990 |
Diseases associated with defects in vitamin B6 metabolism or utilization.
Topics: Alkaline Phosphatase; Arteriosclerosis; Celiac Disease; Female; Hematologic Diseases; Humans; Kidney | 1987 |
[The importance of pyridoxine in the pathology of the nervous system. Review of literature and experimental results of vitamin B 6 deficiency in the rat].
Topics: Animals; Humans; Mental Disorders; Nervous System Diseases; Pyridoxine; Rats; Vitamin B 6 Deficiency | 1967 |
3 trials available for pyridoxine and Nervous System Diseases
| Article | Year |
|---|---|
[Clinical experiences with an analgesic-acting infusion solution in neurological painful conditions].
Topics: Arthritis, Rheumatoid; Aspartic Acid; Dipyrone; Facial Neuralgia; Humans; Injections, Intravenous; M | 1977 |
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study.
Topics: Aged; Altretamine; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged; Nausea; Nervous S | 1979 |
[Relaxation-promoting effect of vitamin B with anabolics].
Topics: Action Potentials; Adult; Anabolic Agents; Androstanes; Attention; Blood Pressure; Cerebral Hemorrha | 1970 |
54 other studies available for pyridoxine and Nervous System Diseases
| Article | Year |
|---|---|
Pyridoxine in pregnant women receiving antituberculous drugs.
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Nervous System Diseases; Pregnancy; Pregnancy Comp | 2009 |
Neurological Wilson disease in children: a three years experience from Multan.
Topics: Adolescent; Age Distribution; Age of Onset; Astringents; Chelating Agents; Child; Child, Preschool; | 2011 |
Pyridoxine (vitamin B6) toxicity: enhancement by uremia in rats.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Male; Nervous System Diseases; Pyridoxine; Rats; Rats, Inb | 2002 |
Dose-dependent effects of glutamate in pyridoxine-induced neuropathy.
Topics: Animals; Ataxia; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Glutamic Acid; Hot | 2003 |
Prophylaxis of isoniazid neuropathy with pyridoxine.
Topics: Humans; Isomerism; Isoniazid; Nervous System Diseases; Niacin; Nicotinic Acids; Peripheral Nervous S | 1956 |
[Usefulness of pyridoxol (vitamin B6) in the treatment of neurological manifestations of alcoholic intoxication].
Topics: Alcoholic Intoxication; Humans; Nervous System Diseases; Pyridoxine; Vitamin B 6 | 1959 |
[gamma-Aminobutyric acid-pyridoxine in the treatment of states of irritability and connected nervous disorders].
Topics: Amino Acids; gamma-Aminobutyric Acid; Irritable Mood; Mental Disorders; Nervous System Diseases; Neu | 1962 |
[A case of convulsions and other neurological disorders caused by deficiency of pyridoxine in an alcoholic].
Topics: Alcoholism; Humans; Nervous System Diseases; Pyridoxine; Seizures; Vitamin B 6 Deficiency | 1962 |
[On the treatment of inflammatory neurological diseases with a vitamin-enzyme combination].
Topics: Adenine Nucleotides; Herpes Zoster; Humans; Multiple Sclerosis; Nervous System Diseases; Neuralgia; | 1962 |
[THE CONTROL OF PAIN STATES IN NEUROLOGICAL DISEASES BY NEUROBION].
Topics: Herpes Zoster; Humans; Nervous System Diseases; Neuralgia; Neuritis; Pain; Phantom Limb; Pyridoxine; | 1963 |
BEHAVIOUR EXPERIMENTS IN RATS. PHARMACOLOGICAL ACTION OF GAMMA AMINOBUTYRIC ACID + VITAMIN B6.
Topics: Aminobutyrates; Animals; Behavior, Animal; Brain Chemistry; gamma-Aminobutyric Acid; Learning; Nervo | 1964 |
[CLINICAL EXPERIMENTATION WITH THE ASCORBO-PYRIDOXINE EQUIMOLECULAR COMPLEX IN ITS NEUROLOGIC INDICATIONS].
Topics: Ascorbic Acid; Biomedical Research; Drug Therapy; Empirical Research; Nervous System Diseases; Pyrid | 1964 |
[SOME DATA ON THE CLINICAL USE OF PYRIDOXINE (VITAMIN B6) IN NEUROLOGICAL DISEASES].
Topics: Drug Therapy; Humans; Nervous System Diseases; Neurasthenia; Pyridoxine; Vitamin B 6 | 1964 |
[TRIAL OF ACTIVATED VITAMINS FOR VARIOUS NERVOUS SYSTEM DISEASES].
Topics: Drug Therapy; Fatty Acids; Fatty Acids, Essential; Humans; Nervous System Diseases; Niacin; Nicotini | 1964 |
Pyridoxine hydrochloride (vitamin B6) in the treatment of neuropathies.
Topics: Humans; Nervous System Diseases; Pyridoxine | 1948 |
Neural toxicity of isonicotinic acid hydrazide (isoniazid) for chickens.
Topics: Animals; Cerebellum; Hematocrit; Isoniazid; Kidney; Liver; Male; Myocardium; Nervous System Diseases | 1967 |
Vitamin B 1, B 2 and B 6 deficiency in neurological disorders.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Coenzymes; Erythrocytes; Female; Glutathione R | 1981 |
The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. I. Clinical disease.
Topics: Animals; Ataxia; Blood Cell Count; Blood Proteins; Clioquinol; Diarrhea; Dogs; Eating; Female; Male; | 1981 |
The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. II. Pathology.
Topics: Animals; Brain; Clioquinol; Diarrhea; Dogs; Female; Male; Myocardium; Nervous System; Nervous System | 1981 |
The effect of vitamin B6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: clinical and laboratory studies.
Topics: Animals; Humans; Mice; Mice, Inbred Strains; Misonidazole; Nervous System Diseases; Nitroimidazoles; | 1984 |
Safety of intermediate doses of pyridoxine.
Topics: Humans; Male; Middle Aged; Nervous System Diseases; Pyridoxine | 1984 |
Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6.
Topics: Action Potentials; Animals; Dogs; Electric Stimulation; Electrophysiology; Female; Locomotion; Motor | 1982 |
Penicillamine-induced neuropathy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Female; Humans; Middle Aged; Nervous System Diseases; Neural Conduction; Peni | 1981 |
Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy.
Topics: Animals; Biological Transport; Female; Motor Activity; Nerve Fibers; Nerve Growth Factors; Nervous S | 1997 |
Acute isoniazid exposures and antidote availability.
Topics: Acute Disease; Antidotes; Antitubercular Agents; Child; Drug Storage; Emergency Medicine; Emergency | 1999 |
[Isoniazid; adverse effects].
Topics: Gastrointestinal Diseases; Humans; Isoniazid; Nervous System Diseases; Pyridoxine | 1975 |
Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nervous System Diseases; | 1992 |
Pyridoxine neuropathy. A four-year electrophysiological and clinical follow-up of a severe case.
Topics: Electrophysiology; Follow-Up Studies; Humans; Male; Middle Aged; Nervous System Diseases; Pyridoxine | 1991 |
Pyridoxine for the palmar-plantar erythrodysesthesia syndrome.
Topics: Dermatitis, Exfoliative; Fluorouracil; Hand Dermatoses; Humans; Male; Middle Aged; Nervous System Di | 1989 |
[Neuro- and embryotoxic side effects of vitamin B6].
Topics: Abnormalities, Drug-Induced; Animals; Dose-Response Relationship, Drug; Female; Humans; Infant, Newb | 1989 |
[A case of primary acquired sideroblastic anemia (PASA) with motor dominant polyneuropathy responsive to vitamin B6].
Topics: Aged; Anemia, Sideroblastic; Female; Humans; Nervous System Diseases; Pyridoxine | 1989 |
Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication.
Topics: Animals; Axons; Cytoplasm; Dose-Response Relationship, Drug; Ganglia, Spinal; Guinea Pigs; Male; Mic | 1989 |
Sensitivity to 4-aminopyridine observed in mammalian sciatic nerves during acute pyridoxine-induced sensory neuropathy and recovery.
Topics: 4-Aminopyridine; Action Potentials; Acute Disease; Aminopyridines; Animals; Female; Nerve Fibers, My | 1988 |
Pyridoxine and the premenstrual syndrome.
Topics: Female; Humans; Nervous System Diseases; Premenstrual Syndrome; Pyridoxine | 1985 |
Successful treatment of infantile type I primary hyperoxaluria complicated by pyridoxine toxicity.
Topics: Acute Kidney Injury; Female; Humans; Infant; Nervous System Diseases; Oxalates; Pedigree; Pyridoxine | 1985 |
Vitamin B6 (pyridoxine) and the premenstrual tension syndrome.
Topics: Female; Humans; Nervous System Diseases; Premenstrual Syndrome; Pyridoxine; Sensation | 1987 |
Characteristics of pyridoxine overdose neuropathy syndrome.
Topics: Dose-Response Relationship, Drug; Female; Humans; Hyperesthesia; Middle Aged; Nervous System Disease | 1987 |
Neuropathy after pyridoxine or toxic contaminants.
Topics: Humans; Nervous System Diseases; Pyridoxine | 1986 |
Zinc-binding proteins in the brain.
Topics: Animals; Carrier Proteins; Epilepsy; Humans; Metalloproteins; Metallothionein; Nerve Tissue Proteins | 1986 |
Differential vulnerability of 3 rapidly conducting somatosensory pathways in the dog with vitamin B6 neuropathy.
Topics: Animals; Dogs; Electric Stimulation; Evoked Potentials, Somatosensory; Female; Locomotion; Muscle Co | 1985 |
Neuropathy in porphyria.
Topics: Humans; Nervous System Diseases; Porphyrias; Pyridoxine; Tryptophan; Vitamin B 6 Deficiency | 1968 |
[Vitamins in neurology].
Topics: Avitaminosis; Folic Acid; Humans; Nervous System; Nervous System Diseases; Niacinamide; Nicotinic Ac | 1969 |
Uremic neuropathy. Monitoring of transketolase activity inhibition in a child.
Topics: Brain; Child; Electromyography; Female; Humans; Kidney Failure, Chronic; Leg; Nervous System Disease | 1973 |
[Study of the therapeutic action of a combination of vitamins B1, B6 and hydroxocobalamin in large doses].
Topics: Adult; Aged; Anemia; Brain Diseases; Epilepsy; Facial Paralysis; Fatty Liver; Female; Hemiplegia; He | 1968 |
[Treatment of the porphyrias].
Topics: Adenine Nucleotides; Barbiturates; Catalase; Cathartics; Chlorpromazine; Cholagogues and Choleretics | 1969 |
[Research on the value of a taurine, nucleotide and vitamin combination in neurologic diseases].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Drug Combinations; Drug Evaluation; Female; Humans; | 1974 |
The pathology of pyridoxine deficiency in chicks.
Topics: Age Factors; Animal Nutritional Physiological Phenomena; Animals; Body Weight; Bone Diseases; Chicke | 1972 |
Effects of pyridoxine deficiency in nervous tissue maintained in vitro.
Topics: Animals; Animals, Newborn; Cerebellum; Culture Techniques; Fetus; Ganglia, Spinal; Hydrazines; Isoni | 1969 |
[Therapeutic use in the neurological field of a new pharmaceutical compound: monophosphate nucleotide (AMP and UMP) with taurine, pyridoxine and cyanocobalamine].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pyridoxine; Taurine; Vitami | 1967 |
Pyridoxine deficiency in celiac disease and the detection of neuropsychiatric disorders.
Topics: Adult; Aged; Celiac Disease; Depression; Female; Humans; Male; Middle Aged; Nervous System Diseases; | 1969 |
[Experience in the prevention by drugs of nervous system lesions in poisoning with fire-proof oil "Ivviol'-3'].
Topics: Accidents, Occupational; Female; Humans; Lubrication; Male; Nervous System Diseases; Oils; Poisoning | 1970 |
[Causal therapy of pain states in neurologic diseases].
Topics: Analgesics; Antipyrine; Humans; Methylamines; Nervous System Diseases; Pain; Pyridoxine; Sulfonic Ac | 1970 |
Effect of phenytoin on the tryptophan load test.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Diagnosis, Differential; Epilepsy; Female; Humans; | 1968 |
Vitamins of the B complex.
Topics: Aged; Alcoholism; Anemia, Hypochromic; Avitaminosis; Beriberi; Heart Failure; Humans; Isoniazid; Ner | 1968 |